The cost‐effectiveness of real‐time pulmonary artery pressure monitoring in heart failure patients: a European perspective

AIMS: Heart failure (HF) treatment guided by physicians with access to real‐time pressure measurement from a wireless implantable pulmonary artery pressure (PAP) sensor (CardioMEMS), has previously been shown to reduce HF‐related hospital admissions in the CHAMPION trial. However, uncertainty remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowie, Martin R., Simon, Marcus, Klein, Liviu, Thokala, Praveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2017
Materias:
Cardiac Devices
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434803/
https://www.ncbi.nlm.nih.gov/pubmed/28176424
http://dx.doi.org/10.1002/ejhf.747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434803/
https://www.ncbi.nlm.nih.gov/pubmed/28176424
http://dx.doi.org/10.1002/ejhf.747

Ejemplares similares